Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, ...

Novo Nordisk has rebounded strongly in 2025, backed by solid financials despite earlier setbacks and competitive risks. See why NVO stock is a buy.

Ever since Frederiksen took office in Denmark in 2019, the second woman and youngest person ever to become prime minister in ...

This month, the Danish prime minister Mette Frederiksen takes up her presidency of the EU – and the timing could not be more ...

In 2004, 100 citizens lived in Ørestaden of Amager. Today, almost 26,000 live in Ørestad Parish alone, Politiken reports. Just over half of all residents in Ørestad Parish are internationals, almost ...

FC Copenhagen will start qualifying for the Champions League. The opponent will be the winner of the match between Differdange from Luxembourg and Drita from Kosovo. Sports director Sune Smith-Nielsen ...

Eli Lilly (LLY 1.15%) and Novo Nordisk (NVO 0.14%) are two phenomenal growth stocks that investors probably can't go wrong ...

Novo Nordisk (NVO) and Eli Lilly & Co. (LLY), the global leaders in obesity medications, are now facing their first major ...

When the collaboration between Novo Nordisk and Hims & Hers was announced in April, Wegovy was made available on Hims through Novo Nordisk’s NovoCare Pharmacy for a discounted price of $499 per ...

Novo Nordisk (NVO -1.00%) stock, maker of the blockbuster GLP-1 agonist weight-loss drugs Ozempic and Wegovy, jumped a lucky 7% through 12:20 p.m. ET Tuesday after London's Financial Times ...

Novo Nordisk has added another dimension to its artificial intelligence ambitions by signing up as a customer of Denmark’s first so-called “supercomputer.” The supercomputer, named Gefion ...